Human Liver Model Market Size, Share & Trends Analysis Report By Product (2D Models, 3D Models), By Application (ADME Studies, Toxicology Testing), By End-use (Academic & Research Institutes), By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Human Liver Model Market Size & Trends
The global human liver model market size was estimated at USD 1.19 billion in 2023 and is projected t%li%grow at a CAGR of 13.8% from 2024 t%li%2030. The market is driven by the increasing prevalence of liver diseases, advancements in organ printing technologies, and increased demand for therapeutic drugs for liver cancer, which is expected t%li%propel its growth.
According t%li%the Health Resources & Services Administration, in 2023, in the U.S., 106,800 individuals are waiting for organ transplants. The healthcare landscape is evolving, and advancements in 3D printing technology are set t%li%transform healthcare by addressing organ shortages and improving patient care globally.
The prevalence of liver diseases is on the rise globally, leading t%li%a growing demand for advanced research tools include Human Liver Model. Chronic liver conditions such as non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, viral hepatitis, and liver cancer are becoming increasingly common due t%li%factors such as unhealthy diets, sedentary lifestyles, alcohol consumption, and viral infections. For instance, NAFLD emerged as the most prevalent chronic liver disorder in Western countries, affecting approximately 25% of the global population. This significant rise in the prevalence of liver diseases has driven the urgent need for more accurate and efficient Human Liver Model t%li%support research and drug development efforts.
Organ 3D printing technologies have advanced significantly recently, particularly in developing Human Liver Model. These advancements have revolutionized regenerative medicine and drug testing by providing more accurate and personalized models for research purposes. For instance, in February 2023, researchers at the University of California San Dieg%li%made significant progress in addressing challenging issues in bi%li%printing 3D-engineered tissues, achieving high cell density, viability, and precise fabrication resolution.
Global Human Liver Model Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 t%li%2030. For this study, Grand View Research has segmented the global human liver model market report based on product, application, end-use, and region:
Human Liver Model Market Size & Trends
The global human liver model market size was estimated at USD 1.19 billion in 2023 and is projected t%li%grow at a CAGR of 13.8% from 2024 t%li%2030. The market is driven by the increasing prevalence of liver diseases, advancements in organ printing technologies, and increased demand for therapeutic drugs for liver cancer, which is expected t%li%propel its growth.
According t%li%the Health Resources & Services Administration, in 2023, in the U.S., 106,800 individuals are waiting for organ transplants. The healthcare landscape is evolving, and advancements in 3D printing technology are set t%li%transform healthcare by addressing organ shortages and improving patient care globally.
The prevalence of liver diseases is on the rise globally, leading t%li%a growing demand for advanced research tools include Human Liver Model. Chronic liver conditions such as non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, viral hepatitis, and liver cancer are becoming increasingly common due t%li%factors such as unhealthy diets, sedentary lifestyles, alcohol consumption, and viral infections. For instance, NAFLD emerged as the most prevalent chronic liver disorder in Western countries, affecting approximately 25% of the global population. This significant rise in the prevalence of liver diseases has driven the urgent need for more accurate and efficient Human Liver Model t%li%support research and drug development efforts.
Organ 3D printing technologies have advanced significantly recently, particularly in developing Human Liver Model. These advancements have revolutionized regenerative medicine and drug testing by providing more accurate and personalized models for research purposes. For instance, in February 2023, researchers at the University of California San Dieg%li%made significant progress in addressing challenging issues in bi%li%printing 3D-engineered tissues, achieving high cell density, viability, and precise fabrication resolution.
Global Human Liver Model Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 t%li%2030. For this study, Grand View Research has segmented the global human liver model market report based on product, application, end-use, and region:
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- 2D Models
- Cell lines
- Primary Cells
- 3D Models
- Liver on Chip
- Organoids
- Spheroids
- Others
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- ADME Studies
- Toxicology Testing
- Disease Modelling
- Others
- End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Regional Outlook (Revenue in USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. HUMAN LIVER MODEL MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of liver diseases
3.2.1.2. Advancements in organ printing technologies
3.2.1.3. Increased demand for therapeutic drugs for liver cancer
3.2.2. Market restraint analysis
3.2.2.1. High costs and complexity associated with maintaining Human Liver Model
3.3. Human Liver Model Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. HUMAN LIVER MODEL MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Product Segment Dashboard
4.2. Global Human Liver Model Market Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Global Human Liver Model Market Size and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. 2D Models
4.4.1. 2D models market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Cell Lines
4.4.2.1. Cell Lines market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Primary Cells
4.4.3.1. Primary Cells market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. 3D Models
4.5.1. 3D models market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2. Liver on Chip
4.5.2.1. Liver on Chip market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Organoids
4.5.3.1. Organoids market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.4. Spheroids
4.5.4.1. Spheroids market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.5. Others
4.5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 5. HUMAN LIVER MODEL MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Application Segment Dashboard
5.2. Global Human Liver Model Market Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Global Human Liver Model Market Size and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. ADME Studies
5.4.1. ADME Studies market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Toxicology Testing
5.5.1. Toxicology Testing market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Disease Modelling
5.6.1. Disease Modelling market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 6. HUMAN LIVER MODEL MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. End Use Segment Dashboard
6.2. Global Human Liver Model Market End Use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Global Human Liver Model Market Size and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Academic & Research Institutes
6.4.1. Academic & Research Institutes market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Pharmaceutical & Bioproduct Companies
6.5.1. Pharmaceutical & Bioproduct Companies market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Contract Research Organizations
6.6.1. Contract Research Organizations market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 7. HUMAN LIVER MODEL MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Human Liver Model Market: Regional Estimates & Trend Analysis by Product, Application, and End Use
7.2. Regional Market Dashboard
7.3. Regional Market Share Analysis, 2023 & 2030
7.4. North America
7.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamics
7.4.4.2. Competitive scenario
7.4.4.3. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. UK market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. France market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamics
7.5.8.2. Competitive scenario
7.5.8.3. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key country dynamics
7.5.9.2. Competitive scenario
7.5.9.3. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. China market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. India market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
7.8. MEA
7.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamics
7.8.4.2. Competitive scenario
7.8.4.3. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamics
7.8.5.2. Competitive scenario
7.8.5.3. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles
8.4.1. ATCC
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Merck KGaA
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. AcceGen
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. ZenBio, Inc.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Organovo Holdings Inc.
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. BioIVT
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. InSphero
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Emulate, Inc.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Mimetas
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. CN Bio Innovations Ltd
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. HUMAN LIVER MODEL MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of liver diseases
3.2.1.2. Advancements in organ printing technologies
3.2.1.3. Increased demand for therapeutic drugs for liver cancer
3.2.2. Market restraint analysis
3.2.2.1. High costs and complexity associated with maintaining Human Liver Model
3.3. Human Liver Model Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. HUMAN LIVER MODEL MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Product Segment Dashboard
4.2. Global Human Liver Model Market Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Global Human Liver Model Market Size and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. 2D Models
4.4.1. 2D models market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Cell Lines
4.4.2.1. Cell Lines market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Primary Cells
4.4.3.1. Primary Cells market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. 3D Models
4.5.1. 3D models market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2. Liver on Chip
4.5.2.1. Liver on Chip market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Organoids
4.5.3.1. Organoids market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.4. Spheroids
4.5.4.1. Spheroids market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.5. Others
4.5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 5. HUMAN LIVER MODEL MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Application Segment Dashboard
5.2. Global Human Liver Model Market Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Global Human Liver Model Market Size and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. ADME Studies
5.4.1. ADME Studies market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Toxicology Testing
5.5.1. Toxicology Testing market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Disease Modelling
5.6.1. Disease Modelling market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 6. HUMAN LIVER MODEL MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. End Use Segment Dashboard
6.2. Global Human Liver Model Market End Use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Global Human Liver Model Market Size and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Academic & Research Institutes
6.4.1. Academic & Research Institutes market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Pharmaceutical & Bioproduct Companies
6.5.1. Pharmaceutical & Bioproduct Companies market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Contract Research Organizations
6.6.1. Contract Research Organizations market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 7. HUMAN LIVER MODEL MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Human Liver Model Market: Regional Estimates & Trend Analysis by Product, Application, and End Use
7.2. Regional Market Dashboard
7.3. Regional Market Share Analysis, 2023 & 2030
7.4. North America
7.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamics
7.4.4.2. Competitive scenario
7.4.4.3. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. UK market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. France market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamics
7.5.8.2. Competitive scenario
7.5.8.3. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key country dynamics
7.5.9.2. Competitive scenario
7.5.9.3. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. China market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. India market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
7.8. MEA
7.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamics
7.8.4.2. Competitive scenario
7.8.4.3. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamics
7.8.5.2. Competitive scenario
7.8.5.3. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles
8.4.1. ATCC
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Merck KGaA
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. AcceGen
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. ZenBio, Inc.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Organovo Holdings Inc.
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. BioIVT
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. InSphero
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Emulate, Inc.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Mimetas
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. CN Bio Innovations Ltd
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviation
Table 2 Global Human Liver Model market, by region, 2018 - 2030 (USD Million)
Table 3 Global Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 4 Global Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 5 Global Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 6 North America Human Liver Model market, by country, 2018 - 2030 (USD Million)
Table 7 North America Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 8 North America Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 9 North America Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 10 U.S. Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 11 U.S. Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 12 U.S. Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 13 Canada Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 14 Canada Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 15 Canada Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 16 Mexico Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 17 Mexico Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 18 Mexico Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe Human Liver Model market, by country, 2018 - 2030 (USD Million)
Table 20 Europe Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 21 Europe Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 22 Europe Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 23 Germany Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 24 Germany Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 25 Germany Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 26 UK Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 27 UK Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 28 UK Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 29 France Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 30 France Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 31 France Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 32 Italy Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 33 Italy Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 34 Italy Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 35 Spain Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 36 Spain Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 37 Spain Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 38 Denmark Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 39 Denmark Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 40 Denmark Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 41 Sweden Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 42 Sweden Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 43 Sweden Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 44 Norway Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 45 Norway Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 46 Norway Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Human Liver Model market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 51 China Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 52 China Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 53 China Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 54 Japan Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 55 Japan Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 56 Japan Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 57 India Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 58 India Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 59 India Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 60 South Korea Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 61 South Korea Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 62 South Korea Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 63 Australia Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 64 Australia Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 65 Australia Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 66 Thailand Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 67 Thailand Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 68 Thailand Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 69 Latin America Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 70 Latin America Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 71 Latin America Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 72 Brazil Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 73 Brazil Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 74 Brazil Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 75 Argentina Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 76 Argentina Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 77 Argentina Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 78 MEA Human Liver Model market, by region, 2018 - 2030 (USD Million)
Table 79 MEA Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 80 MEA Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 81 MEA Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 82 South Africa Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 83 South Africa Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 84 South Africa Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 88 UAE Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 89 UAE Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 90 UAE Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 91 Kuwait Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 92 Kuwait Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 93 Kuwait Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 1 List of abbreviation
Table 2 Global Human Liver Model market, by region, 2018 - 2030 (USD Million)
Table 3 Global Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 4 Global Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 5 Global Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 6 North America Human Liver Model market, by country, 2018 - 2030 (USD Million)
Table 7 North America Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 8 North America Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 9 North America Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 10 U.S. Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 11 U.S. Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 12 U.S. Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 13 Canada Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 14 Canada Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 15 Canada Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 16 Mexico Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 17 Mexico Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 18 Mexico Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe Human Liver Model market, by country, 2018 - 2030 (USD Million)
Table 20 Europe Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 21 Europe Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 22 Europe Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 23 Germany Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 24 Germany Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 25 Germany Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 26 UK Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 27 UK Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 28 UK Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 29 France Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 30 France Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 31 France Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 32 Italy Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 33 Italy Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 34 Italy Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 35 Spain Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 36 Spain Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 37 Spain Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 38 Denmark Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 39 Denmark Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 40 Denmark Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 41 Sweden Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 42 Sweden Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 43 Sweden Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 44 Norway Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 45 Norway Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 46 Norway Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Human Liver Model market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 51 China Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 52 China Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 53 China Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 54 Japan Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 55 Japan Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 56 Japan Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 57 India Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 58 India Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 59 India Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 60 South Korea Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 61 South Korea Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 62 South Korea Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 63 Australia Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 64 Australia Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 65 Australia Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 66 Thailand Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 67 Thailand Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 68 Thailand Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 69 Latin America Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 70 Latin America Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 71 Latin America Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 72 Brazil Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 73 Brazil Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 74 Brazil Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 75 Argentina Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 76 Argentina Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 77 Argentina Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 78 MEA Human Liver Model market, by region, 2018 - 2030 (USD Million)
Table 79 MEA Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 80 MEA Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 81 MEA Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 82 South Africa Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 83 South Africa Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 84 South Africa Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 88 UAE Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 89 UAE Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 90 UAE Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 91 Kuwait Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 92 Kuwait Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 93 Kuwait Human Liver Model market, by end use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Precision genomic testing market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL analysis
Fig. 19 Precision genomic testing market: Product outlook key takeaways
Fig. 20 Precision genomic testing market: Product movement analysis
Fig. 21 Consumables market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 22 Kits market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 23 Plasmids market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 24 Reagents market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 25 Equipment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 26 Services market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 27 Precision genomic testing market: Application outlook key takeaways
Fig. 28 Precision genomic testing market: Application movement analysis
Fig. 29 Oncology market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 30 Cardiovascular diseases market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 31 Neurological disorders market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 32 Reproductive health market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 33 Rare diseases market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 35 Precision genomic testing market: Technology outlook key takeaways
Fig. 36 Precision genomic testing market: Technology movement analysis
Fig. 37 Next-generation sequencing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 38 Polymerase chain reaction market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 39 Microarray technology market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 40 Sanger sequencing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 41 CRISPR/Cas systems market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 42 Others market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 43 Precision genomic testing market: End-use outlook key takeaways
Fig. 44 Precision genomic testing market: End-use movement analysis
Fig. 45 Hospitals and clinics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 46 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 47 Research & academic institutes companies market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 48 Others market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 49 Regional marketplace outlook, 2023 & 2030 (USD billion)
Fig. 50 Regional marketplace: Key takeaways
Fig. 51 North America precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 52 Key country dynamics
Fig. 53 U.S. precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 54 Key country dynamics
Fig. 55 Canada precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 56 Key country dynamics
Fig. 57 Mexico precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 58 Europe precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 59 Key country dynamics
Fig. 60 UK precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 61 Key country dynamics
Fig. 62 Germany precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 63 Key country dynamics
Fig. 64 France precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 65 Key country dynamics
Fig. 66 Spain precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 67 Key country dynamics
Fig. 68 Italy precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 69 Key country dynamics
Fig. 70 Denmark precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 71 Key country dynamics
Fig. 72 Sweden precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 73 Key country dynamics
Fig. 74 Norway precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 75 Asia Pacific precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 76 Key country dynamics
Fig. 77 Japan precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 78 Key country dynamics
Fig. 79 China precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 80 Key country dynamics
Fig. 81 India precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 82 Key country dynamics
Fig. 83 Australia precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 84 Key country dynamics
Fig. 85 South Korea precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 86 Key country dynamics
Fig. 87 Thailand precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 88 Key country dynamics
Fig. 89 Market participant categorization
Fig. 90 Precision genomic testing market position analysis, 2023
Fig. 91 Strategic framework
Fig. 1 Precision genomic testing market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL analysis
Fig. 19 Precision genomic testing market: Product outlook key takeaways
Fig. 20 Precision genomic testing market: Product movement analysis
Fig. 21 Consumables market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 22 Kits market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 23 Plasmids market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 24 Reagents market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 25 Equipment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 26 Services market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 27 Precision genomic testing market: Application outlook key takeaways
Fig. 28 Precision genomic testing market: Application movement analysis
Fig. 29 Oncology market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 30 Cardiovascular diseases market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 31 Neurological disorders market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 32 Reproductive health market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 33 Rare diseases market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 35 Precision genomic testing market: Technology outlook key takeaways
Fig. 36 Precision genomic testing market: Technology movement analysis
Fig. 37 Next-generation sequencing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 38 Polymerase chain reaction market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 39 Microarray technology market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 40 Sanger sequencing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 41 CRISPR/Cas systems market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 42 Others market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 43 Precision genomic testing market: End-use outlook key takeaways
Fig. 44 Precision genomic testing market: End-use movement analysis
Fig. 45 Hospitals and clinics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 46 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 47 Research & academic institutes companies market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 48 Others market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 49 Regional marketplace outlook, 2023 & 2030 (USD billion)
Fig. 50 Regional marketplace: Key takeaways
Fig. 51 North America precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 52 Key country dynamics
Fig. 53 U.S. precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 54 Key country dynamics
Fig. 55 Canada precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 56 Key country dynamics
Fig. 57 Mexico precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 58 Europe precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 59 Key country dynamics
Fig. 60 UK precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 61 Key country dynamics
Fig. 62 Germany precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 63 Key country dynamics
Fig. 64 France precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 65 Key country dynamics
Fig. 66 Spain precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 67 Key country dynamics
Fig. 68 Italy precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 69 Key country dynamics
Fig. 70 Denmark precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 71 Key country dynamics
Fig. 72 Sweden precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 73 Key country dynamics
Fig. 74 Norway precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 75 Asia Pacific precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 76 Key country dynamics
Fig. 77 Japan precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 78 Key country dynamics
Fig. 79 China precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 80 Key country dynamics
Fig. 81 India precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 82 Key country dynamics
Fig. 83 Australia precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 84 Key country dynamics
Fig. 85 South Korea precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 86 Key country dynamics
Fig. 87 Thailand precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 88 Key country dynamics
Fig. 89 Market participant categorization
Fig. 90 Precision genomic testing market position analysis, 2023
Fig. 91 Strategic framework
